pyrazines has been researched along with angiotensin ii in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 9 (36.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boddy, K; Brown, JJ; Davies, DL; Fraser, R; Kremer, D; Lever, AF; Morton, JJ; Robertson, JI | 1 |
| Antunes-Rodrigues, J; Ramalho, MJ; Reis, LC | 1 |
| Beevers, DG; Brown, JJ; Davies, DL; Ferriss, JB; Fraser, R; Kremer, D; Lever, AF; Robertson, JI | 1 |
| Cumming, AM; Fraser, R; Leckie, B; Mason, P; Millar, JA; Robertson, JI | 1 |
| Fraser, R; Hettiarachchi, J; Morton, JJ; Ramsay, LE | 1 |
| Matsumori, A; Sasayama, S | 1 |
| Hata, Y; Kawazoe, T; Kosaka, H; Yoneyama, H | 1 |
| Guo, ZQ; Wang, SR; Zhu, LQ | 1 |
| Chan, P; Chen, CH; Cheng, TH; Kao, PF; Lee, WS; Liu, JC; Yang, HY | 1 |
| Napier, A; Thompson, RN; Wekesa, KS | 1 |
| Lu, J; Qu, ZL; Ren, XY; Ruan, QR; Zhu, DH; Zhu, M | 1 |
| Cheng, TH; Chou, YH; Hong, HJ; Wong, KL; Wu, KC; Wu, RS | 1 |
| Jackson, EK; Mi, Z | 1 |
| Combs, K; Daunert, S; Deo, S; Ensor, C; Qu, X; Rowe, L | 1 |
| Jiang, LD; Lu, XY; Qin, Y; Wang, SR; Wu, AM; Zhang, DM; Zhu, LQ | 1 |
| Fujihara, H; Hashimoto, H; Nagatomo, T; Ohbuchi, T; Otsubo, H; Saito, T; Suzuki, H; Ueta, Y; Yokoyama, T | 1 |
| Bilan, VP; Jackson, EK; Tofovic, DS | 1 |
| Gao, MH; Li, B; Ren, SR; Zhang, B; Zhang, L | 1 |
| Sun, YK; Wang, SR; Yu, Y | 1 |
| Nie, H; Ran, X; Zeng, Z | 1 |
| Cheng, M; Han, L; Li, M; She, T; Shi, C; Yu, L | 1 |
| Kost, CK; Li, S; Li, Y; Martin, DS; Wang, X | 1 |
| Chen, L; Kong, D; Lian, N; Lu, Y; Wu, X; Zhang, F; Zhang, X; Zheng, S | 1 |
| He, GW; Liu, XC; Mak, SK; Sun, WT; Yang, Q; Yu, CM | 1 |
| Deng, F; Fang, S; Zhang, B; Zhang, Y | 1 |
1 review(s) available for pyrazines and angiotensin ii
| Article | Year |
|---|---|
Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments.
Topics: Adjuvants, Immunologic; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomyopathy, Dilated; Cardiotonic Agents; Cardiovirus Infections; Cytokines; Encephalomyocarditis virus; Heart Failure; Humans; Mice; Myocarditis; Prodrugs; Pyrazines; Quinolines; Tetrazoles; Tumor Necrosis Factor-alpha | 1995 |
24 other study(ies) available for pyrazines and angiotensin ii
| Article | Year |
|---|---|
Amiloride in the treatment of primary hyperaldosteronism and essential hypertension.
Topics: Adult; Aged; Amiloride; Angiotensin II; Electrolytes; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Pyrazines; Renin | 1977 |
Central serotonergic modulation of drinking behavior induced by angiotensin II and carbachol in normally hydrated rats: effect of intracerebroventricular injection of MK-212.
Topics: Angiotensin II; Animals; Carbachol; Drinking Behavior; Injections, Intraventricular; Male; Pyrazines; Rats; Serotonin | 1990 |
Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes.
Topics: Adrenocortical Hyperfunction; Amiloride; Angiotensin II; Body Water; Corticosterone; Diuretics; Extracellular Space; Humans; Hyperaldosteronism; Hypertension; Plasma Volume; Potassium; Pyrazines; Renin; Secretory Rate; Sodium; Spironolactone; Urea | 1973 |
Metabolic effects of high dose amiloride and spironolactone: a comparative study in normal subjects.
Topics: Adult; Aldosterone; Amiloride; Angiotensin II; Dose-Response Relationship, Drug; Endocrine Glands; Humans; Male; Metabolism; Mineralocorticoids; Potassium; Pyrazines; Renin; Sodium; Spironolactone; Time Factors | 1984 |
Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
Topics: Adult; Aldosterone; Amiloride; Angiotensin II; Bendroflumethiazide; Bicarbonates; Blood Pressure; Diuretics; Female; Humans; Hypertension; Hypokalemia; Male; Middle Aged; Placebos; Potassium; Potassium Chloride; Pyrazines; Sodium; Sodium Chloride Symporter Inhibitors; Spironolactone | 1980 |
Involvement of superoxide in acute reaction of angiotensin II in mesenteric microcirculation.
Topics: Angiotensin II; Animals; Arginine; Enzyme Inhibitors; Imidazoles; Luminescent Measurements; Male; Mesenteric Arteries; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Oxygen; Pyrazines; Rats; Rats, Inbred WKY; Splanchnic Circulation; Superoxide Dismutase; Superoxides; Vasoconstriction; Vasoconstrictor Agents | 1999 |
[Effect of danshensu and ligustrazine on related genes of myocardial hypertrophy induced by angiotensin II].
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Drugs, Chinese Herbal; Female; Lactates; Male; Myocytes, Cardiac; Pyrazines; Rats; Rats, Wistar; RNA, Messenger | 2005 |
Tetramethylpyrazine downregulates angiotensin II-induced endothelin-1 gene expression in vascular endothelial cells.
Topics: Angiotensin II; Antioxidants; Blotting, Northern; Blotting, Western; Cells, Cultured; Chloramphenicol O-Acetyltransferase; Down-Regulation; Endothelial Cells; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Humans; Phosphorylation; Promoter Regions, Genetic; Pyrazines; Reactive Oxygen Species; Recombinant Fusion Proteins; RNA, Messenger; Superoxides; Transfection | 2005 |
Attenuation of the production of inositol 1,4,5-trisphosphate in the mouse vomeronasal organ by antibodies against the alphaq/11 subfamily of G-proteins.
Topics: Angiotensin II; Animals; Antibodies; Cell Membrane; Diglycerides; Dose-Response Relationship, Drug; Enzyme Activation; Female; GTP-Binding Protein alpha Subunits, Gq-G11; Inositol 1,4,5-Trisphosphate; Ketones; Male; Mice; Peptides; Pyrazines; Type C Phospholipases; Vomeronasal Organ | 2006 |
Tetramethylpyrazine inhibits agiontensin II-induced nuclear factor-kappaB activation and bone morphogenetic protein-2 downregulation in rat vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Atherosclerosis; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Immunohistochemistry; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Pyrazines; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2007 |
Tetramethylpyrazine inhibits angiotensin II-increased NAD(P)H oxidase activity and subsequent proliferation in rat aortic smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Cell Proliferation; Cells, Cultured; DNA; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Male; Muscle, Smooth, Vascular; NADPH Oxidases; Pyrazines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Transcription Factor AP-1; Vasodilator Agents | 2007 |
Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension.
Topics: Angiotensin II; Animals; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Hypertension, Renal; Kidney; Male; Neuropeptide Y; Peptide Fragments; Pyrazines; Rats; Rats, Inbred SHR; Renal Circulation; Sitagliptin Phosphate; Sympathetic Nervous System; Triazoles; Vasoconstrictor Agents | 2008 |
Genetically modified semisynthetic bioluminescent photoprotein variants: simultaneous dual-analyte assay in a single well employing time resolution of decay kinetics.
Topics: 6-Ketoprostaglandin F1 alpha; Aequorin; Angiotensin II; Animals; Escherichia coli; Half-Life; Imidazoles; Immunoassay; Kinetics; Mutation; Protein Engineering; Pyrazines | 2008 |
[Effects of tetramethylpyrazine on angiotensin II -induced proliferation and type I collagen synthesis of rat cardiac fibroblasts].
Topics: Angiotensin II; Animals; Animals, Newborn; Cell Proliferation; Collagen Type I; Fibroblasts; Myocardium; Pyrazines; Rats, Sprague-Dawley | 2009 |
TRPV1 gene deficiency attenuates miniature EPSC potentiation induced by mannitol and angiotensin II in supraoptic magnocellular neurons.
Topics: Analysis of Variance; Angiotensin II; Anilides; Animals; Capsaicin; Chelating Agents; Cinnamates; Diuretics, Osmotic; Drug Interactions; Egtazic Acid; Enzyme Inhibitors; In Vitro Techniques; Male; Mannitol; Mice; Mice, Inbred C57BL; Mice, Knockout; Miniature Postsynaptic Potentials; Neurons; Piperidines; Pyrazines; Pyrazoles; Pyridines; Rats; Rats, Wistar; Signal Transduction; Supraoptic Nucleus; TRPV Cation Channels; Vasoconstrictor Agents | 2010 |
Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome.
Topics: Angiotensin II; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Glycated Hemoglobin; Hypertension; Kidney; Male; Metabolic Syndrome; Proteinuria; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Sitagliptin Phosphate; Triazoles; Vasoconstriction; Vasoconstrictor Agents | 2010 |
[Effect of tetramethylpyrazine on JAK-STAT signal transduction in cardiomyocyte hypertrophy].
Topics: Angiotensin II; Animals; Cells, Cultured; Hypertrophy; Janus Kinases; Myocytes, Cardiac; Pyrazines; Rats; Rats, Wistar; Signal Transduction; STAT Transcription Factors | 2011 |
[Effects of ligustrazine on the mitochondrial structure and functions in the process myocardial hypertrophy].
Topics: Angiotensin II; Animals; Cardiomyopathy, Hypertrophic; Cells, Cultured; Electron Transport Complex IV; Mitochondria, Heart; Monoamine Oxidase; Myocytes, Cardiac; Pyrazines; Rats; Rats, Sprague-Dawley | 2012 |
[Effect of tetramethylpyrazine on Nogo gene regulation of the proliferation in cardiac fibroblast].
Topics: Angiotensin II; Animals; Animals, Newborn; Cell Proliferation; Cells, Cultured; Collagen Type I; Fibroblasts; Gene Expression Regulation; Male; Myelin Proteins; Myocytes, Cardiac; Nogo Proteins; Pyrazines; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2012 |
Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-κB-dependent mechanism.
Topics: Angiotensin II; Animals; Cell Enlargement; Cells, Cultured; Enzyme Activation; Gene Expression Regulation; Hypertrophy; Myocytes, Cardiac; NF-kappa B; Protein Biosynthesis; Protein Transport; Pyrazines; Rats; Signal Transduction; Tumor Necrosis Factor-alpha | 2013 |
Bortezomib, a proteasome inhibitor, attenuates angiotensin II-induced hypertension and aortic remodeling in rats.
Topics: Angiotensin II; Animals; Aorta; Boronic Acids; Bortezomib; Cell Proliferation; Extracellular Matrix; Gene Expression Regulation; Hypertension; Male; Proteasome Inhibitors; Pyrazines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Vascular Cell Adhesion Molecule-1 | 2013 |
Tetramethylpyrazine inhibits angiotensin II-induced activation of hepatic stellate cells associated with interference of platelet-derived growth factor β receptor pathways.
Topics: Angiotensin II; Animals; Apoptosis; Cell Division; Cell Proliferation; Flow Cytometry; G2 Phase; Hepatic Stellate Cells; Male; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyrazines; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; TOR Serine-Threonine Kinases | 2014 |
Tetramethylpyrazine suppresses angiotensin II-induced soluble epoxide hydrolase expression in coronary endothelium via anti-ER stress mechanism.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Animals; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; Endothelial Cells; Epoxide Hydrolases; In Vitro Techniques; Pyrazines; Sus scrofa; Tunicamycin; Vasodilation; Vasodilator Agents | 2017 |
Ligustrazine prevents basilar artery remodeling in two-kidney-two-clip renovascular hypertension rats via suppressing PI3K/Akt signaling.
Topics: Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Endothelin-1; Hypertension, Renovascular; Ligation; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Pyrazines; Rats, Sprague-Dawley; Renal Artery; Signal Transduction; Temporal Arteries; Vascular Remodeling | 2020 |